Tracheal occlusion stimulates cell cycle progression and type I cell differentiation in lungs of fetal rats

1 Cardiovascular Research Institute, and Departments of 2 Pediatrics and 3 Surgery, University of California, San Francisco, California 94118 Submitted 15 August 2002 ; accepted in final form 31 March 2003 Fetal tracheal occlusion (TO) has been reported to stimulate lung growth but decreases number...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology. Lung cellular and molecular physiology Vol. 285; no. 2; pp. 344 - L353
Main Authors Yoshizawa, Jyoji, Chapin, Cheryl J, Sbragia, Lourenco, Ertsey, Robert, Gutierrez, Jorge A, Albanese, Craig T, Kitterman, Joseph A
Format Journal Article
LanguageEnglish
Published United States 01.08.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:1 Cardiovascular Research Institute, and Departments of 2 Pediatrics and 3 Surgery, University of California, San Francisco, California 94118 Submitted 15 August 2002 ; accepted in final form 31 March 2003 Fetal tracheal occlusion (TO) has been reported to stimulate lung growth but decreases number and maturation of type II cells, effects that vary with gestational age and duration of TO. We examined effects of a novel method of TO (unipolar microcautery to seal the trachea) produced at 19.5–20 days (d) of gestation in fetal rats; fetuses were delivered at term, 22 d. Controls were sham operated and unoperated littermates. TO increased wet lung weight but not dry lung weight or lung DNA and protein. To evaluate further the effects of TO, we examined the cell cycle regulators, cyclins D1 and A, in fetal lungs. Cyclin D1 increased with TO ( P < 0.005). TO also increased expression of the type I epithelial cell marker RTI 40 (mRNA and protein). TO decreased mRNA for surfactant proteins (SP)-A and -C but did not affect protein levels of SP-A and -B and of RTII 70 , a type II epithelial cell marker. We conclude that TO by microcautery, even of short duration, has diverse pulmonary effects including stimulating increased levels of cyclin D1 with probable cell cycle progression, type I cell differentiation, and possibly inhibiting type II cell function. cyclins; fetal lung development; lung growth; pulmonary epithelial differentiation; pulmonary surfactant Address for reprint requests and other correspondence: C. J. Chapin, Univ. of California, San Francisco, Cardiovascular Research Institute, Box 1245, 3333 California St., Ste. 150, San Francisco, CA 94118 (E-mail: cheri{at}itsa.ucsf.edu ).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1040-0605
1522-1504
DOI:10.1152/ajplung.00281.2002